Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years - 21/11/24
, H. Joosten 2, R.T. Gansevoort 3, J.P.J. Slaets 1, G.J. Izaks 1
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Poor cognitive performance is associated with high vascular risk. However, this association is only investigated in elderly. As neuropathological changes precede clinical symptoms of cognitive impairment by several decades, it is likely that cognitive performance is already associated with vascular risk at middle-age.
Objectives |
To investigate the association of cognitive performance with treatable vascular risk in middle-aged and old persons.
Design |
Longitudinal study with three measurements during follow-up period of 5.5 years.
Setting |
City of Groningen, the Netherlands.
Participants |
Cohort of 3,572 participants (age range, 35–82 years; mean age, 54 years; men, 52%).
Exposure |
Treatable vascular risk as defined by treatable components of the Framingham Risk Score for Cardiovascular Disease at the first measurement (diabetes mellitus, smoking, hypercholesterolemia and hypertension).
Measurements |
Change in cognitive performance during follow-up. Cognitive performance was measured with Ruff Figural Fluency Test (RFFT) and Visual Association Test (VAT), and calculated as the average of the standardized RFFT and VAT score per participant.
Results |
The mean (SD) cognitive performance changed from 0.00 (0.79) at the first measurement to 0.15 (0.83) at second measurement and to 0.39 (0.82) at the third measurement (Ptrend<0.001). This change was negatively associated with treatable vascular risk: the change in cognitive performance between two measurements decreased with 0.004 per one-point increment of treatable vascular risk (95%CI, -0.008 to 0.000; P=0.05) and with 0.006 per one-year increment of age (95%CI, -0.008 to -0.004; P<0.001).
Conclusions |
Change in cognitive performance was associated with treatable vascular risk in persons aged 35 years or older.
Le texte complet de cet article est disponible en PDF.Key words : Cognitive performance, treatable vascular risk, longitudinal analysis, cardiovascular disease, preventing cognitive impairment
Plan
Vol 6 - N° 1
P. 42-49 - janvier 2019 Retour au numéro
Article précédent
- Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer’s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study
- V. Pérez-Grijalba, J. Romero, Pedro Pesini, L. Sarasa, I. Monleón, I. San-José, J. Arbizu, P. Martínez-Lage, J. Munuera, A. Ruiz, L. Tárraga, M. Boada, M. Sarasa, The AB255 Study Group
- Diet as a Risk Factor for Cognitive Decline in African Americans and Caucasians with a Parental History of Alzheimer’s Disease: A Cross-Sectional Pilot Study Dietary Patterns
- A.C. Nutaitis, S.D. Tharwani, M.C. Serra, F.C. Goldstein, L. Zhao, S.S. Sher, D.D. Verble, Whitney Wharton
Bienvenue sur EM-consulte, la référence des professionnels de santé.